Compare ITW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITW | SIGA |
|---|---|---|
| Founded | 1912 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.6B | 341.0M |
| IPO Year | 1994 | 2016 |
| Metric | ITW | SIGA |
|---|---|---|
| Price | $245.71 | $4.26 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $263.45 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 432.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | 2.42% | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $14,768,000,000.00 | N/A |
| Revenue This Year | $4.27 | N/A |
| Revenue Next Year | $3.44 | $224.81 |
| P/E Ratio | $94.10 | ★ N/A |
| Revenue Growth | ★ 3.17 | N/A |
| 52 Week Low | $238.82 | $4.10 |
| 52 Week High | $303.16 | $9.62 |
| Indicator | ITW | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 33.47 | 35.19 |
| Support Level | $242.68 | N/A |
| Resistance Level | $247.85 | $4.86 |
| Average True Range (ATR) | 5.03 | 0.18 |
| MACD | -0.85 | -0.02 |
| Stochastic Oscillator | 10.52 | 20.00 |
Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.